Ovarian tumours and adnexal masses encompass a broad spectrum of pathologies, ranging from benign cysts to aggressive malignancies. Accurate and early diagnosis is critical due to the high mortality ...

Early satiety is a major red flag of ovarian cancer and should be addressed immediately. Here’s what you need to know.

A gynecologic oncologist at the Mayo Clinic who treats patients with ovarian cancer shares the warning signs she looks for in ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...

Ovarian cancer is the eighth most common cancer among women. [1] Owing to the slow progression and initial vague symptoms of the disease, many cases are diagnosed at an advanced stage, when treatments ...

In a recent paper published in Nature, researchers at the University of Chicago discovered how to block nicotinamide N-methyl transferase (NNMT), an enzyme that is involved in the progression of ...

First women’s health test marks a new chapter for InterVenn, providing access to non-invasive testing that differentiates between cancerous and benign pelvic masses for improved treatment planning ...

Dr. Lauren Juyia first learned she had cancer last year, when she was just 37. A young Florida doctor who discovered her own cancer last year is opening up about her personal health journey in the ...

Frequent urination is often linked to bladder or urinary tract issues, but experts warn it can also be an early sign of ovarian cancer. As tumours grow, they may press on the bladder, causing ...

JSKN003, a biparatopic anti-HER2 antibody drug conjugate (ADC), in the treatment of platinum-resistant ovarian cancer (PROC): Updated findings from two clinical trials. This is an ASCO Meeting ...